Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

GSK’s Votrient gains new licence

August 8, 2012 Sales and Marketing GSK, NICE, Votrient, soft cell sarcoma

GlaxoSmithKline has gained a new European licence for its cancer pill Votrient adding to its renal cell carcinoma licence. The …
News

Champix better than patches for smoking cessation

August 7, 2012 Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking

New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …
News

Horizon Discovery appoints chief financial officer

August 7, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott

Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …
Appointment

What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry

August 7, 2012 Sales and Marketing e-detailing, sales, sales reps

E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …
Feature
Thought Leadership

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012 Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …
News

Merck’s Singulair faces generic rivals

August 7, 2012 Sales and Marketing Merck, Singulair, generic erosion, patent

Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …
News

Whitehead to GPs: don’t squeeze the drugs budget

August 7, 2012 Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform

GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …
News

Sanofi’s colorectal cancer drug gains FDA approval

August 6, 2012 Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer

The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …
News

Talentmark appoints director of Managed Services

August 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark

Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …
Appointment

ABPI outlines vision for drug pricing reform

August 3, 2012 Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
News

GSK submits melanoma drugs for regulatory approval

August 3, 2012 Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology

GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …
News

Government healthcare fund pays up

August 3, 2012 Research and Development, Sales and Marketing ABPI, MRC, SMEs, government

A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …
News

Teva makes two senior executive appointments

August 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Aharon (Arik) Yaari, Carlo De Notaristefani, Teva

Teva has announced the appointments of Dr Carlo De Notaristefani as president and chief executive of Global Operations, and Aharon …
Appointment

Pfizer Sandwich site sold to private consortium

August 3, 2012 Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
News

Shire posts strong quarter results

August 2, 2012 Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026